Drawing for QUYSPA

USPTO serial 87128557

QUYSPA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HACK, ANDREA R
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with QUYSPA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

CHRISTOPHER M. HANES GSK5 MOORE DRIVE5.5A, LGTMRESEARCH TRIANGLE PARK, NC 27709

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 27, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 27, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 14, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 14, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 14, 2020CNSISUSPENSION INQUIRY WRITTEN—
Jan 13, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 7, 2020ALIEASSIGNED TO LIE—
Jan 7, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 21, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 14, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 8, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 6, 2017ALIEASSIGNED TO LIE—
Oct 31, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 31, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Oct 31, 2016CNSLSUSPENSION LETTER WRITTEN—
Oct 29, 2016DOCKASSIGNED TO EXAMINER—
Aug 9, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 9, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance